James Jacobs, DPM
Foot Surgery · Katy, TXNPI 1033114822
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $76,750 of the $80,786 with a category attached, or 95.0%. Fuse Medical, Inc. accounts for 95.6% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2019 at $51,346 and has fallen 96.5% since, to $1,778 in 2025. Among foot surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $727.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fuse Medical, Inc.$77K
- Stryker$492
- Sandoz$462
- Sanara Medtech Inc.$289
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$271
- Boston Scientific$220
- plus $2K from 29 others
Across 4 payments — averaging $8743.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tyber Medical, LLC$35K
What the payments were for
- Consulting fees$76,75095%
- Travel & lodging$1060%
- Food & beverage$3,9315%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fuse Medical, Inc. | 12 | $77,263 |
| Stryker | 11 | $492 |
| Sandoz | 25 | $462 |
| Sanara Medtech Inc. | 2 | $289 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $271 |
| Boston Scientific | 3 | $220 |
| Voom Medical Devices, Inc. | 2 | $203 |
| AbbVie | 1 | $169 |
| Smith+Nephew | 7 | $157 |
| Lifenet Health | 1 | $154 |
| Orthofix Medical, Inc. | 2 | $113 |
| Averitas Pharma Inc. | 2 | $98 |
| Alafair Biosciences, Inc. | 2 | $81 |
| Zyla Life Sciences, Inc. | 4 | $76 |
| CPM Medical Consultants, LLC | 1 | $75 |
| Amgen(2 entities) | 4 | $74 |
| Organogenesis Inc. | 3 | $66 |
| Bioventus LLC | 4 | $64 |
| Melinta Therapeutics, LLC | 2 | $53 |
| Treace Medical Concepts, Inc. | 1 | $47 |
| ANI Pharmaceuticals, Inc. | 2 | $47 |
| Zimmer Biomet | 1 | $41 |
| Nevro Corp. | 1 | $33 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Mayne Pharma Commercial LLC | 1 | $29 |
| Anika Therapeutics, Inc. | 1 | $28 |
| Abbott | 1 | $21 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Triad Life Sciences Inc. | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| KCI USA, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $14 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orbitum Staple System$1,750
- CellerateRx$289
- DALVANCE$169
- TheraGenesis Wound Matrix$154
- FLOWTRIEVER CATHETER, S$140
- CT THROMBECTOMY SYSTEM KIT$140
- KERYDIN$125
- ALTRENO$118
- SILIQ$118
- ASNIS$109
- REVCON INSTRUMENT KIT, STERILE$106
How this compares
$80,786 in reported general payments places this provider in the 95th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 31 | $25,174 |
| Clobetasol Propionate | 282 | $15,991 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 319 | $11,754 |
| Ciclopirox | 266 | $8,095 |
| Diclofenac Sodium | 156 | $6,912 |
| Ketoconazole | 75 | $1,728 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 57 | $1,308 |
| Meloxicam | 322 | $1,081 |
| Gabapentin | 72 | $493 |
| Cephalexin | 99 | $437 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 42 | $402 |
| Terbinafine Hcl | 29 | $336 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $328 |
| Ammonium Lactate | 18 | $301 |
| Clotrimazole | 13 | $219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $271 | $25,17431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 71 foot surgery providers in Texas.
Other foot surgery in Katy
- Phillip ApplegateKaty$987
- Marque AllenSan Antonio$204K
- Lawrence LaverySan Antonio$59K
- Robert GraserBoerne$54K
- Richard KehSan Antonio$17K
- Chad ClauseWebster$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Fernando CruzCorsicana$12K
- Richard GalperinDallas$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.